• Blog
  • Reviews
  • Contact US
    Sign in Sign up
    • Psychiatry Education Forum Academy
    • PEFA Network
    • Blog
    • Reviews
    • Dashboard
    • Contact Us

    Category: Psychiatry-In-Depth

    Restless Leg Syndrome: How to Diagnose, Evaluate & Treat

    Restless leg syndrome is a common neurological condition, which can be easily missed or misdiagnosed as insomnia. On the other hand, most antidepressants and antipsychotics…

    Dr. Harvinder Singh September 17, 2022

    Managing Treatment Resistant Depression with Atypical Features

    Depression with atypical features is defined as significant mood reactivity combined with two of the following clinical features: Hyperphagia Hypersomnia Leaden paralysis Pathological rejection sensitivity…

    Dr. Harvinder Singh September 14, 2022

    Predictors of Suicidal Ideation after Stroke?

    Post-stroke depression is considered one of the common neuropsychiatric complications of cerebrovascular stroke, affecting approximately one third of stroke survivors at any one time after…

    Dr. Harvinder Singh September 2, 2022

    Auvelity: New Oral Fast Acting FDA Approved Antidepressant

    On Aug 19, 2022 Axsome Therapeutics announced the FDA Approval of Auvelity, as the first and Only Oral NMDA Receptor Antagonist for the treatment of…

    Dr. Harvinder Singh August 22, 2022

    How to Evaluate Six Neurocognitive Domains in Dementia: Social Cognition

    It is important to have knowledge of these six neuro-cognitive domains for the evaluation & diagnosis of dementia subtypes. In this discussion series, Dr. Harvinder…

    Dr. Harvinder Singh August 13, 2022

    Postpartum Psychosis Management?

    Postpartum psychosis is a psychiatric emergency that warrants immediate treatment, including admission to ensure the safety of mother and baby. Understanding the treatment algorithm for…

    Dr. Harvinder Singh August 3, 2022

    OCD Psychopharmacology Algorithm: 3 Days Lecture Series

    Psychiatry Education Forum Academy is announcing our next lecture series, where Dr. David Osser will discuss the psychopharmacology algorithm project’s recent update on the psychopharmacological…

    Dr. Harvinder Singh July 25, 2022

    Low Testosterone Level & Depression: Should you check?

    Psychiatry Education Forum Academy is excited to announce the release of our 17th journal club discussion. This journal club will focus on this clinically relevant…

    Dr. Harvinder Singh July 18, 2022

    FDA Authorized Diagnostic Aid for Autism Spectrum Disorder

    Autism spectrum disorder (ASD) is one of the most common developmental disorders. The importance of early ASD diagnosis is of clinical importance, as early interventions…

    Dr. Harvinder Singh June 15, 2022

    Journal Club 16: Lithium use during Pregnancy & Postpartum

    Psychiatry Education Forum Academy is excited to release our 16th journal club discussion today. This journal club will focus on this clinically relevant topic of…

    Dr. Harvinder Singh May 22, 2022

    OCD: When to Discontinue Treatment?

    Let’s begin by answering this question first: APA 2007 guideline recommends that successful medication treatment for OCD be continued for 1–2 years before considering a…

    Dr. Harvinder Singh May 21, 2022

    Binge Eating Disorder: Diagnose & Treatment?

    Lifetime prevalence estimates of DSM-IV anorexia nervosa, bulimia nervosa, and binge eating disorder are .9%, 1.5%, and 3.5% among women, and .3% .5%, and 2.0%…

    Dr. Harvinder Singh May 18, 2022

    Urine Drug Test: Phencyclidine

    Phencyclidine abuse can cause violent and aggressive behaviors, severe hallucinations, paranoia, and impaired motor skills. Few medications can cause false-positive results can occur for agents…

    Dr. Harvinder Singh April 17, 2022

    Urine Drug Tests: Amphetamines

    Amphetamine screening tests are most commonly associated with false positive tests and this includes false positive results from psychotropic medications as well.  Let’s begin by…

    Dr. Harvinder Singh April 14, 2022

    Urine Drug Tests: Benzodiazepines

    LECTURE SERIES DAY 3: RELEASED TODAY We continue our lecture series on the “Clinical Interpretation of Urine Drug Tests” with a discussion on the following…

    Dr. Harvinder Singh April 11, 2022

    Urine Drug Screen: Opioids

    LECTURE SERIES DAY 2: RELEASED TODAY We continue our lecture series on the “Clinical Interpretation of Urine Drug Tests” with a discussion on the following…

    Dr. Harvinder Singh April 9, 2022

    Urine Drug Screen: Cannabinoids

    LECTURE SERIES DAY 1: RELEASED TODAY Today we begin this clinically relevant lecture series for our academy members with videos on the following two topics:…

    Dr. Harvinder Singh April 8, 2022

    Clinical Interpretation of Urine Drug Tests: Journal Club 15

    Psychiatry Education Forum Academy has released the complete lecture schedule for our academy members today: CLINICAL INTERPRETATION OF URINE DRUG TESTS It is important to…

    Dr. Harvinder Singh April 5, 2022

    Managing Severe Melancholic Depression

    Melancholic features in major depressive disorder are characterized by: ONE of the following present during the most severe period of the current episode: Loss of…

    Dr. Harvinder Singh April 2, 2022

    Parkinson’s Disease & Impulse Control Disorders

    Psychiatry Education Forum Academy’s lecture series on “Impulse Control & Self Injurious Behaviors: Pharmacological Management” has released the next lecture today: Parkinson’s Disease & Impulse…

    Dr. Harvinder Singh March 15, 2022

    Academy Post Summary: Feb 2022

    In February 2022, Psychiatry Education Forum Academy added the following 6 clinically relevant chapters. Please let me know if you found them clinically relevant. (1)…

    Dr. Harvinder Singh February 28, 2022

    Journal Club 14: Dose-Response Meta-Analysis of Antipsychotics for Acute Schizophrenia

    Psychiatry Education Forum Academy is excited to release our next journal club discussion today. This journal club will focus on this clinically relevant topic of…

    Dr. Harvinder Singh February 19, 2022

    Journal Club’s New Feature: ABCC Pathway Track

    Psychiatry Education Forum’s Journal Club is an additional feature for our Academy’s members. We are excited to announce the release of our new feature in…

    Dr. Harvinder Singh February 13, 2022

    Serotonin Syndrome: 5 Clinical Facts

    Serotonin syndrome is considered a psychiatric emergency, characterized by excess of serotonin in central nervous system, which if severe can become life threatening. We have…

    Dr. Harvinder Singh January 19, 2022

    Top 5 Viewed Posts in 2021

    On this last day of 2021, let’s review our top 5 viewed posts of this year: Bipolar Disorder Psychopharmacology (1) Restarting Lamotrigine after abrupt Discontinuation…

    Dr. Harvinder Singh December 31, 2021

    Anti-NMDAR Encephalitis: What should you know as a Psychiatrist?

    Anti-NMDA Receptor Encephalitis This is an autoimmune disorder in which antibodies attack NMDA (N-methyl D aspartate) type glutamate receptors at central neuronal synapses. Psychiatrists should…

    Dr. Harvinder Singh December 11, 2021

    What Features Differentiates Bipolar Depression from MDD?

    Q: What Features Differentiate Bipolar Depression from MDD? Bipolar depression is characterized by significantly higher rates of: Psychomotor retardation Difficulty thinking Early morning awakening, morning worsening…

    Dr. Harvinder Singh November 8, 2021

    Bipolar Disorder with Mixed Features: Update 2021

    Bipolar disorder is a chronic mood disorder associated with various mood states including mania, hypomania, depression, and mixed states. The identification and treatment of mixed…

    Dr. Harvinder Singh October 11, 2021

    Geriatric Psychiatry: Neurocognitive Disorders [PEFA Discussions]

    Alzheimer’s disease is the most common type/cause of dementia. As we know that FDA recently approved Aducanumab (Aduhelm) for the treatment of Alzheimer’s Disease (read…

    Dr. Harvinder Singh September 28, 2021

    Testosterone & Depression in Men?

    Age-associated hypogonadism (testosterone deficit) can occurs in 30% of men after the age of 55 (1). Low testosterone is associated with decreased muscle mass, bone…

    Dr. Harvinder Singh August 24, 2021

    How to Screen for Delirium Superimposed on Dementia?

    When delirium and dementia coexist: this is referred to as delirium superimposed on dementia (DSD). Delirium and dementia are associated with: lengthier hospital stays functional…

    Dr. Harvinder Singh August 21, 2021

    How to Differentiate Obsessions from Delusions?

    The presence of obsessive-compulsive symptoms (OCS) and obsessive-compulsive disorders (OCD) in schizophrenia is frequent. It is of clinical relevance to separate obsessive symptoms from delusional…

    Dr. Harvinder Singh August 15, 2021

    Attention PEFA Members: Join PEFA Network

    Dear PEFA Members.  We are excited to release a new update in our academy: PEFA Network. This is a closed group for PEFA members only and…

    Dr. Harvinder Singh August 13, 2021

    Traumatic Brain Injury: Management Series [PEFA]

    The risk for psychiatric disorders and symptoms can increase after the traumatic brain injury, and long-term disability from TBI has primarily been attributed to neurobehavioral…

    Dr. Harvinder Singh August 8, 2021

    Message Each Other: New PEFA Feature

    Today we are excited to announce the release of our website’s new feature for PEFA members. Now PEFA members can message each other privately to…

    Dr. Harvinder Singh July 31, 2021

    How to Evaluate Six Neurocognitive Domains in Dementia? [PUBLISHED]

    Psychiatry Education Forum Academy published its next discussion series today: It is important to have knowledge of these six neuro-cognitive domains for the evaluation &…

    Dr. Harvinder Singh July 24, 2021

    How to Evaluate Six Neurocognitive Domains in Dementia?

    Today we are excited to announce Psychiatry Education Forum Academy’s next discussion with release date for this Saturday (July 24): It is important to have…

    Dr. Harvinder Singh July 20, 2021

    Psycho-Ophthalmology: Psychotropics Ocular Adverse Events

    Psychotropic medications are known to cause ocular side effects. We have a detailed section on this topic in Psychiatry Education Forum Academy.  Let’s begin with…

    Dr. Harvinder Singh July 9, 2021

    [PEFA Journal Club]: Claim 4.75 CME Credits

    We just finished our 13 journal club discussions at PEFA (Psychiatry Education Forum Academy). PEFA members can claim a maximum of 4.75 AMA PRA Category…

    Dr. Harvinder Singh June 26, 2021

    [Journal Club 13 + Coffee Club]: International Trauma Questionnaire (ITQ) for PTSD & CPTSD

    Today we posted the following 13th journal club in PEFA Journal Club’s discussion series and discussion with an expert in our Coffee Club’s discussion section:…

    Dr. Harvinder Singh June 23, 2021

    [Journal Club #12 + Coffee Club]: Is Ketamine Safe with History of Psychosis?

    Today we posted the following 12th journal club in PEFA Journal Club’s discussion series and discussion with an expert in our Coffee Club’s discussion section:…

    Dr. Harvinder Singh June 23, 2021

    [Journal Club #6 + #7]: Two New Schizophrenia Medications with Novel Mechanism of Action

    Today we posted the sixth and seventh journal club in PEFA Journal Club’s discussion series, discussing the following two newer antipsychotics for schizophrenia treatment: (A)…

    Dr. Harvinder Singh June 18, 2021

    [Journal Club #5 + Coffee Club]: Comparing 32 Oral Antipsychotics for Acute Schizophrenia Management.

    Today we posted the following fifth journal club in PEFA Journal Club’s discussion series and discussion with a expert in our Coffee Club’s discussion section:…

    Dr. Harvinder Singh June 17, 2021

    Journal Club #4: How Does Schizophrenia Symptoms Progress with Age?

    Today we posted the following fourth journal club in PEFA Journal Club’s discussion series: Journal Club #4: Staging of Schizophrenia With the Use of PANSS:…

    Dr. Harvinder Singh June 16, 2021

    Journal Club #3: Bipolar Depression Guidelines: CANMAT & ISBD Versus Psychopharmacology Algorithm Project

    Today we posted the following third journal club in PEFA Journal Club’s discussion series: Journal Club #3: The Psychopharmacology Algorithm Project at the Harvard South…

    Dr. Harvinder Singh June 14, 2021

    Journal Club #2: Omega-3 Fatty Acids for MDD Treatment (ISNPR Practice Guidelines)

    Today we posted the following second journal club in PEFA Journal Club’s discussion series: Journal Club #2: International Society for Nutritional Psychiatry Research Practice Guidelines…

    Dr. Harvinder Singh June 14, 2021

    Journal Club #1: Update on Nonpsychotic Unipolar Depression Management

    We begin PEFA Journal Club’s updated schedule with our first journal club discussion today: Journal Club #1: The Psychopharmacology Algorithm Project at the Harvard South…

    Dr. Harvinder Singh June 13, 2021

    PEFA Journal Club: Updated Schedule Released

    Psychiatry Education Forum’s Journal Club is an additional feature for PEF Academy’s members. All academy members will be automatically enrolled in this journal club. Here…

    Dr. Harvinder Singh June 11, 2021

    Antipsychotics of Choice during Lactation

    Antipsychotics of Choice During Lactation: This PEFA academy chapter will summarize the use of antipsychotics during lactation in the following sections: FIRST-LINE treatment options during…

    Dr. Harvinder Singh June 9, 2021

    Aducanumab: New Medication FDA Approved for Alzheimer’s Disease

    June 07, 2021 Today FDA has approved Aducanumab (Aduhelm) for the treatment of Alzheimer’s Disease. This is the first novel treatment to target the underlying…

    Dr. Harvinder Singh June 7, 2021

    LYBALVI™: New Medication FDA Approved for Schizophrenia & Bipolar Disorder

    June 01, 2021 Today FDA approved LYBALVI for the treatment of: Schizophrenia in adults Bipolar I disorder in adults Acute treatment of manic or mixed…

    Dr. Harvinder Singh June 1, 2021

    PEFA Newsletter: May 2021

    PSYCHIATRY EDUCATION FORUM ACADEMY’S NEWSLETTER MAY 2021 Here is the summary of topics posted in the month of May at Psychiatry Education Forum Academy. These…

    Dr. Harvinder Singh May 31, 2021

    How do Schizophrenia Symptoms Progress over 40 years?

    Today (May 24) is World Schizophrenia Day. The purpose of this day is to increase awareness and reduce the stigma associated with the diagnosis of…

    Dr. Harvinder Singh May 24, 2021

    Psychological Approaches for Auditory Hallucinations Management

    Antipsychotic medications are commonly used to treat auditory hallucinations but it is equally important to teach patients these psychological skills to reduce the distress associated…

    Dr. Harvinder Singh May 11, 2021

    Medications vs Psychotherapy for MDD: Comparing 5 Major Guidelines

    How do you decide between psychotherapy versus medications for the treatment of major depressive disorder? Depression severity is one of the criteria used to make…

    Dr. Harvinder Singh May 8, 2021

    Pseudobulbar Affect: Identify & Manage

    Psychiatry Education Forum Academy’s Coffee Club contains short discussions with clinical experts in the field of psychiatry. Coffee Club’s goal is to get answers for clinically…

    Dr. Harvinder Singh April 26, 2021

    Treatment-Resistant GAD: 8 Augmentation & 12 Switching Options

    Psychiatry Education Forum Academy will publish a detailed lecture on the management options for treatment-resistant GAD (Generalized Anxiety Disorder) tomorrow: April 18 (Sunday). This detailed…

    Dr. Harvinder Singh April 17, 2021

    Genetic Testing in Psychiatry: MTHFR & L-MethylFolate

    MTHFR gene encodes for MethyleneTetraHydroFolate Reductase (MTHFR) enzyme. It is important to have the knowledge of the following two MTHFR polymorphisms for you to interpret…

    Dr. Harvinder Singh April 12, 2021

    PEF Clinical Fact: Antipsychotic of Choice in COVID & Pneumonia

    INTERESTED IN LEARNING MORE? JOIN PSYCHIATRY EDUCATION FORUM ACADEMY MEMBERSHIP This educational activity is dedicated to the essential and must-know clinical facts regarding the interaction…

    Dr. Harvinder Singh January 27, 2021

    Can L-Theanine Help with Anxiety Management?

    Share this post Share on facebook Share on google Share on twitter Share on linkedin Share on pinterest Share on print Share on email L-theanine…

    Dr. Harvinder Singh January 23, 2021

    Top 5 Psychiatry Articles Discussed on PEF

    Happy New Year to all PEF Followers I want to thank you all for following Psychiatry Education Forum and giving me the encouragement to continue…

    Dr. Harvinder Singh December 31, 2020

    Role of ANK3 in Bipolar Disorder

    Share this post Share on facebook Share on google Share on twitter Share on linkedin Share on pinterest Share on print Share on email Ankyrin-3…

    Dr. Harvinder Singh December 29, 2020

    Grief, Persistent Complex Bereavement Disorder Versus Prolonged Grief Disorder

    This topic will be summarized in the following three sections:  (1) Grief versus Major Depressive Episode: https://youtu.be/WIQmiWnqhFg (2) Persistent Complex Bereavement Disorder Versus Prolonged Grief…

    Dr. Harvinder Singh October 27, 2020

    Treatment-Resistant PTSD Nightmares Management

    Today we released our updated lecture series on the management of treatment-resistant PTSD nightmares management. With this lecture series, we have crossed 260 chapters in…

    Dr. Harvinder Singh October 3, 2020

    Beware of “Benadryl Challenge” on TikTok: FDA Warning

    You must be aware of life-threatening challenges posted on social media in past, including the Tide Pod Challenge (in 2018) and the Bird Box Challenge…

    Dr. Harvinder Singh September 27, 2020

    Why Patients with Dementia develop Behavioral Symptoms?

    Behavioral Symptoms Management in Dementia Lecture Series  This lecture series will be discussed in the following sections: 1. Types of agitated behaviors in dementia: (Duration:…

    Dr. Harvinder Singh September 26, 2020

    FDA Update: Boxed Warning for Benzodiazepines

    On Sep 23, 2020: FDA released this new announcement in their Drug Safety Communication, that the following update will be included in the Boxed Warning…

    Dr. Harvinder Singh September 25, 2020

    Evidence-Based Prevention Guidelines of Alzheimer’s Disease

    This most recent study published by Jin-Tai Yu et al in J Neurol Neurosurg Psychiatry (on Jul 20, 2020) completed a systematic review & meta-analysis…

    Dr. Harvinder Singh August 28, 2020

    25% Price Drop: 1st CME Conference

    Psychiatry Education Forum’s first CME online conference is dedicated to the essential and must-know clinical facts in psychiatry. This conference will offer a maximum of 10 AMA…

    Dr. Harvinder Singh August 22, 2020

    Peer Reviewer for Psychiatry Education Forum

    We are currently working on exciting educational activities for Psychiatry Education Forum subscribers. We at Psychiatry Education Forum rely on reliable peer review process to…

    Dr. Harvinder Singh August 14, 2020

    Cognitive Impairment with Traumatic Brain Injury

    Traumatic brain injury can significantly impact an individual’s life, in terms of cognitive, behavioral and physical impairments. Among these, cognitive impairments are often the most…

    Dr. Harvinder Singh August 6, 2020

    PEF Coffee Club: Bipolar Depression

    Psychiatry Education Forum’s (PEF) Coffee Club is a new feature for Physician’s Guide for Clinical Psychiatry course subscribers. PEF Coffee Club contains short discussions with…

    Dr. Harvinder Singh July 25, 2020

    Treatment-Resistant OCD: Can NAC Help?

    A 36 year-old-female with history of Obsessive-Compulsive Disorder (OCD) is currently on fluvoxamine 300 mg/day with clomipramine 250 mg/day with persistence of intrusive obsessive thoughts…

    Dr. Harvinder Singh July 14, 2020

    ‘Breaking Bad’ on a Routine Urine Drug Screen: The case of an innocent drug-positive

    Post Contribution by Dr. Lena Palaniyappan Often we request urine drug screening when we suspect possible drug use, but cannot trust what the patient says.…

    Dr. Harvinder Singh June 20, 2020

    The Fire of Psychosis

    Journalists write a lot more than psychiatrists, right?  But how can you write meaningfully when your “brain is on fire”? A 24 year old New…

    Dr. Harvinder Singh June 7, 2020

    Atypical Psychosis: Discussion Series Announcement

    Psychiatry Education Forum is excited to announce the release of our upcoming discussion series with Dr. Lena Palaniyappan:  <h2>ATYPICAL PSYCHOSIS:</h2> <img width=”640″ height=”360″ src=”https://psychiatryeducationforum.com/project1/wp-content/uploads/2020/05/Dr.-Lena-Palaniyappan2–1024×576.jpg” alt=””…

    Dr. Harvinder Singh May 29, 2020

    Psychotropic Dose Conversions: Email Lecture Series

    We will begin the following email lecture series for Physician’s Guide for Clinical Psychiatry course subscribers: PSYCHOTROPICS DOSE CONVERSION (MAY 18- MAY 29, 2020) (May…

    Dr. Harvinder Singh May 17, 2020

    Duloxetine FDA Approved for Pediatric Fibromyalgia (age 13-17 yr)

    FDA has expanded the duloxetine indication for the treatment of fibromyalgia in pediatric population (age 13-17 yr). Duloxetine is now approved for following disorders: Major…

    Dr. Harvinder Singh May 16, 2020

    Non-Psychiatric Medications with: Neuropsychiatric Adverse Events (Email Lecture Series)

    Physician’s Guide for Clinical Psychiatry’s Next Triweekly Email Lecture Series Announcement:  In this email lecture series, we will discuss the neuropsychiatric adverse events from following…

    Dr. Harvinder Singh April 28, 2020

    Neuroleptic Malignant Syndrome: Diagnostic Criteria

    This post is dedicated to the discussion of diagnostic criteria for neuroleptic malignant syndrome. Here is the summary of an international consensus study of Neuroleptic…

    Dr. Harvinder Singh April 21, 2020

    Catatonia: Kahlbaum & Kraepelin

    REFERENCES: Book: CATATONIA. From Psychopathology to Neurobiology. (HIGHLY RECOMMENDED) (amazon) Kahlbaum KL: Klinische Abhandlungen über psychische Krankheiten. 1. Heft: Die Katatonie oder das Spannungsirresein. Berlin,…

    Dr. Harvinder Singh April 14, 2020

    Burning Mouth Syndrome and Psychotropic Medications

    Today we are excited to announce that we crossed 250 chapters in Physician’s Guide for Clinical Psychiatry Course.  Here is Chapter #252 (which is available…

    Dr. Harvinder Singh April 11, 2020

    Clozapine, REMS and COVID-19

    FDA issued the statement on March 22, 2020 regarding the patient access to REMS (Risk Evaluation and Mitigation Strategy) medications like clozapine during COVID-19 public…

    Dr. Harvinder Singh April 7, 2020

    Psychotropics Induced Sexual Dysfunction

    Physician’s Guide for Clinical Psychiatry’s next lecture series will discuss the psychotropics sexual side effects in the following six chapters/emails: (1) WHAT QUESTIONS TO ASK? (MARCH…

    Dr. Harvinder Singh March 25, 2020

    Tobacco Use Disorder: Lecture Series

    The Tobacco Use Disorder email lecture series will be discussed in the following sections: (1) Varenicline: (March 16) Mechanism Dosing instruction Comparison to bupropion Effect…

    Dr. Harvinder Singh March 15, 2020

    Do SSRIs have Active Metabolite?

    References: Fuller RW, Snoddy HD, Krushinski JH, Robertson DW. Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo. Neuropharmacology. 1992 Oct;31(10):997-1000. (PubMed PMID: 1279447)…

    Dr. Harvinder Singh March 2, 2020

    Depression & Hypothyroidism: 8 Clinical Facts

    References: Minerva Endocrinol. 2013 Dec;38(4):365-77. (pubmed) J Affect Disord. 2014 Dec;169:112-7. (pubmed) Arch Intern Med. 2010 Dec 13;170(22):1996-2003. (pubmed) Psychoneuroendocrinology. 2015 Aug;58:114-9. (pubmed) Facebook Twitter…

    Dr. Harvinder Singh February 25, 2020

    Psychotherapy of Choice for PTSD?

    FOR PHYSICIAN’S GUIDE FOR CLINICAL PSYCHIATRY SUBSCRIBERS: (Read Chapter 11.1): VA/DOD Clinical Practice Guidelines for PTSD and Acute Stress Disorder. This chapter will summarize these…

    Dr. Harvinder Singh February 14, 2020

    FDA Warning: Increased Cancer Risk with Lorcaserin

    On 01-14-2020, FDA released this alert of possible association of cancer with Lorcaserin: FDA mentioned that at this time, the cause of the cancer is…

    Dr. Harvinder Singh January 21, 2020

    DAYVIGO™ (Lemborexant): FDA Approved for Insomnia.

    On Dec 23, 2019 Eisai Inc. announced the FDA approval of DAYVIGO™ (Lemborexant) for insomnia management. This post will summarize the important clinically relevant facts…

    Dr. Harvinder Singh December 30, 2019

    Our Top 5 Posts & Lecture Series of 2019: Happy New Year

    We hope you had an amazing 2019! We sure did, thanks to all of your support over the past year. I want to say a…

    Dr. Harvinder Singh December 29, 2019

    Lumateperone (Caplyta): New Antipsychotic Approved for Schizophrenia

    FDA has approved this new antipsychotic CAPLYTA (lumateperone) for the treatment of schizophrenia. This post will summarize the important clinically relevant facts regarding this medication,…

    Dr. Harvinder Singh December 23, 2019
    1 Comment

    FDA Warning: Gabapentin and Serious Breathing Difficulties

    FDA issued the following warning on 12/19/2019, and requires this information to be included in the package insert of this medication class:  Combination of Gabapentinoids…

    Dr. Harvinder Singh December 20, 2019

    Autism Spectrum Disorder: Pharmacological Management

    Autism spectrum disorder is a neuro-developmental disorder characterized by deficits in social communication and social reciprocity, as well as repetitive behavior and restricted interests.  First…

    Dr. Harvinder Singh October 19, 2019

    Antidepressants: Mechanism of Action (Part-2)

        (Q.1): Which of the following antidepressant medication acts via: 5HT-2 Antagonism 5HT-3 Antagonism Alpha 2 Antagonism   Venlafaxine Mirtazapine Vortioxetine Vilazodone   (Q.2):…

    Dr. Harvinder Singh September 17, 2019

    Antidepressants: Mechanism of Action (Part-1)

        (Q.1): Which of the following antidepressant medication acts via: 5HT-2 Antagonism 5HT-3 Antagonism Alpha 2 Antagonism Venlafaxine Mirtazapine Vortioxetine Vilazodone   (Q.2): Which…

    Dr. Harvinder Singh September 12, 2019

    Duration of Antipsychotic use after Mania Remission.

    Before proceeding further: Submit your answer first ANSWER: (c) 6 MONTHS (a) Continuing antipsychotics beyond 6 months (24 weeks) may not further protect against mania recurrence…

    Dr. Harvinder Singh September 9, 2019

    Triweekly Email Summary Published (Sep 2019)

    Click here for more details: https://course-email-summary.subscribemenow.com/ Free preview of our email sent today: Bipolar Disorder Guidelines: Mania (CANMAT & ISBD): http://bit.ly/Email-Summary-Bipolar-1

    Dr. Harvinder Singh September 2, 2019

    Join our Email Newsletter

    Dear Psychiatry Education Forum Members. We send 1-2 educational emails/week to our email subscribers. We have upgraded to a new email service provider and this…

    Dr. Harvinder Singh August 15, 2019

    Lead Poisoning in Children

    This post will be summarized by answering the following questions: (Q.1): What are the Neurological and Non-Neurological Symptoms of Lead Poisoning? (Q.2): What are the…

    Dr. Harvinder Singh August 8, 2019

    Excoriation (Skin-Picking) Disorder Management

    Management of Excoriation (Skin-Picking) disorder will be discussed in the following two chapters (video podcasts). This brings our total course chapters count to 225. In…

    Dr. Harvinder Singh August 1, 2019

    Physician’s Guide for Clinical Psychiatry: 6 Months Anniversary Announcements.

    Physician’s Guide for Clinical Psychiatry course was released 6 months ago on Jan 19 with 180 chapters. We just published our 222nd chapter yesterday (= 42 chapters…

    Dr. Harvinder Singh July 20, 2019

    Suicide Risk Evaluation

    Suicide risk assessment is the most important aspect of psychiatric evaluation. This video podcast will discuss the clinical factors that may increase or decrease the…

    Dr. Harvinder Singh July 14, 2019

    Top 3 Most Viewed Posts Last Week

    Before this summary, I want to thank you all for subscribing to our YouTube channel (Psychiatry Education Forum): we crossed 100 subscribers this week 🙂…

    Dr. Harvinder Singh July 7, 2019

    Mental Status Exam: Back to Basics

    Hello Friends. This post is dedicated to our new PGY1 psychiatry residents. This video podcast will summarize the basic details of a mental status examination. Highly recommended…

    Dr. Harvinder Singh July 4, 2019

    Psychiatry Education Forum Updates (June 2019)

    Hello Friends. June is almost over and so is half of 2019 🙂 How are you all liking our posts so far? Please do not…

    Dr. Harvinder Singh June 28, 2019

    Bipolar 2 vs 1 Disorder?

    Detailed Answer Posted Here:

    Dr. Harvinder Singh June 23, 2019

    Behavioral Symptoms Management in Dementia: Lecture Series.

    Welcome to Behavioral Symptoms Management in Dementia Lecture Series. This post will summarize the list of chapters (based on their release dates). Here is our…

    Dr. Harvinder Singh May 2, 2019

    Premenstrual Dysphoric Disorder (PMDD)

    This is our fifth video podcast and will be summarized in the following sections: Diagnosing PMDD. PMS vs PMDD. Evaluating PMDD with Scales. Treatment Options:…

    Dr. Harvinder Singh April 20, 2019

    FDA Psychiatric Medication Shortages (April 2019)

    Following Psychiatric medications are CURRENTLY IN SHORTAGE: (1) Buspirone (2) Diazepam Injection (3) Diphenhydramine Injection (4) Flurazepam Hydrochloride Capsules (5) Fluvoxamine ER Capsules (6) Haloperidol…

    Dr. Harvinder Singh April 9, 2019

    FDA Approved Zulresso (brexanolone) for Post-partum Depression.

    FDA approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. Mechanism: Brexanolone is positive allosteric modulator…

    Dr. Harvinder Singh March 20, 2019

    Updated Guidelines by International Society of Psychiatric Genetics

    International Society of Psychiatric Genetics (ISPG) updated their guidelines on the use of genetic testing in psychiatric practice. Here is a summary of these recommendations:…

    Dr. Harvinder Singh March 18, 2019

    Delirium Rating Scale-Revised-98 (DRS-R-98)

    Delirium screening tools such as the Confusion Assessment Method and the Delirium Symptom Interview: are designed to detect some delirium symptoms but not to measure…

    Dr. Harvinder Singh March 16, 2019

    Antipsychotics Induced Edema.

    Answer: C ↓ ↓ (190th Chapter Added to Course): Free preview available for next 48 hours only: Chapter #(2.8): Antipsychotics Induced Edema: Evaluation & Management.…

    Dr. Harvinder Singh February 22, 2019

    Somatic Symptom and Related Disorders (#2): Management of Medically Unexplained Symptoms in Primary Care.

    Kroenke (1) published the following stepped approach for evaluation and management of medically unexplained symptoms in primary care setting: STEP #1: Determine Severity (a) for acutely…

    Dr. Harvinder Singh January 16, 2019

    Somatic Symptom and Related Disorders (#1): Differentiating Disorders.

    DSM-5 Somatic Symptom & Related Disorders includes: Somatic Symptom Disorder Illness Anxiety Disorder Conversion Disorder (Functional Neurological Symptom Disorder) Psychological Factors Affecting Other Medical Conditions…

    Dr. Harvinder Singh January 14, 2019

    Catatonia (#3): Treatment with Benzodiazepines.

    FIRST LINE MEDICATION: BENZODIAZEPINES (LORAZEPAM). Route of administration: IV or IM preferred over oral. Initiating dose of lorazepam: 2 mg (Lorazepam Challenge Test) Examine patient…

    Dr. Harvinder Singh January 10, 2019

    Catatonia (#2): Catatonic Disorder Due to Another Medical Condition: 293.89 (F06.1)

    This post will focus on likely causes for catatonia secondary to underlying medical conditions. DSM-5 defines this as Catatonic Disorder Due to Another Medical Condition:…

    Dr. Harvinder Singh January 8, 2019

    Catatonia (#1): History of Catatonia: Kahlbaum & Kraepelin.

    Kahlbaum is well known for his monograph “Catatonia or Tension Insanity“, where he described catatonic symptoms as having behavioral and motor components. He described this…

    Dr. Harvinder Singh January 6, 2019

    Stimulant and Guanfacine combination for ADHD: (#3) Comorbid Oppositional Symptoms in ADHD.

    The following study by Robert L. Findling et al tested the effect of guanfacine extended release (GXR) adjunctive to a psychostimulant on oppositional symptoms in…

    Dr. Harvinder Singh December 8, 2018

    Stimulant and Guanfacine combination for ADHD: (#2) Cognitive Effects.

    The following study done by Dr. James T. McCracken et al tested the effects of stimulant and guanfacine monotherapies relative to combined treatment on cognitive functions important in ADHD.…

    Dr. Harvinder Singh December 5, 2018

    Stimulant and Guanfacine combination for ADHD: (#1) Cardiovascular Effects.

      Q: Is this combination safe and well tolerated from cardiovascular side effect profile of individual medications?   Stimulants are known for increase in pulse…

    Dr. Harvinder Singh December 3, 2018

    Lithium and Risk of Hypercalcemia & Hyperparathyroidism

    This post will focus on: Differentiate Lithium associated hypercalcemia/hyperparathyroidism from primary hyperparathyroidism. Symptoms of hypercalcemia.  Monitoring guideline.        LITHIUM ASSOCIATED HYPER-CALCEMIA/ HYPER-PARATHYROIDISM PRIMARY HYPER-PARATHYROIDISM…

    Dr. Harvinder Singh November 28, 2018

    Prevent our Weekly Emails in Spam Folder

      Dear Psychiatry Education Forum Members and Physician’s Guide for Clinical Psychiatry Subscribers.  I have noticed that only 60-70% of our emails are going to…

    Dr. Harvinder Singh November 18, 2018
    1 Comment

    Restarting Lamotrigine after abrupt Discontinuation.

    (Q.1): Patient is stable on Lamotrigine but suddenly stopped it due to rash. Lamotrigine can be restarted (without need for titration) within how many days of…

    Dr. Harvinder Singh November 17, 2018

    Top 5 Viewed Posts in October 2018.

        Here is our list of top five viewed posts in October.    POST #1: Trazodone for Treatment of Major Depressive Disorder.   This…

    Dr. Harvinder Singh November 11, 2018

    Maudsley Staging Method (MSM) for Treatment Resistant Depression (TRD)

    This post will answer following three questions: How to use and score Maudsley Staging Method (MSM) for treatment resistant depression (TRD)?  What is the optimal…

    Dr. Harvinder Singh October 13, 2018

    Major Depression Disorder: Sleep-Wake Cycle & Antidepressants.

      BEFORE SCROLLING DOWN ==> SUBMIT YOUR ANSWERS FIRST 🙂 . . . .   BRAIN STRUCTURES (AND NEUROTRANSMITTERS) IMPLICATED IN SLEEP WAKE CYCLE:  …

    Dr. Harvinder Singh August 21, 2018

    Antidepressants Discontinuation Syndrome Vs Depression Relapse

    Q: How can you clinically differentiate antidepressants discontinuation syndrome from relapse and recurrence of underlying depression?   (1) SYMPTOMS: Distinctive symptom of discontinuation is dizziness, which…

    Dr. Harvinder Singh August 11, 2018
    1 Comment

    Designer Drugs: Clinical Features

      BEFORE SCROLLING DOWN ==> SUBMIT YOUR ANSWERS FIRST 🙂 . . . . Designer drugs are synthetic analogs of controlled substances. This post will…

    Dr. Harvinder Singh August 3, 2018

    United Kingdom Parkinsons Disease Society Brain Bank Clinical Diagnostic Criteria’s

      Diagnosis of a parkinsonian syndrome   Bradykinesia and at least one of the following: Muscular rigidity. Rest tremor (4-6 Hz). Postural instability unrelated to…

    Dr. Harvinder Singh August 2, 2018

    Fibromyalgia

      BEFORE SCROLLING DOWN ==> SUBMIT YOUR ANSWERS FIRST 🙂 . . . . Fibromyalgia is combination of widespread chronic musculoskeletal pain, fatigue and sleep…

    Dr. Harvinder Singh July 22, 2018

    Diabetes Mellitus: Non-Insulin Treatment Options

        BEFORE SCROLLING DOWN ==> SUBMIT YOUR ANSWERS FIRST 🙂 . . . . . . . . .         This…

    Dr. Harvinder Singh July 16, 2018

    Psychiatry Education Forum Survey

       

    Dr. Harvinder Singh July 7, 2018

    Rule out: Hypogonadisim or Low Testosterone

    Rule out: Hypogonadisim or Low Testosterone     HOW TO MAKE THIS DIAGNOSIS: Consistent symptoms and signs + unequivocally low serum testosterone levels.   Initial…

    Dr. Harvinder Singh June 6, 2018

    Anti-NMDA Receptor Encephalitis.

    Anti-NMDA Receptor Encephalitis This is an autoimmune disorder in which antibodies attack NMDA (N-methyl D aspartate) type glutamate receptors at central neuronal synapses.    CLINICAL…

    Dr. Harvinder Singh May 28, 2018

    Psychiatry & Co-Morbid Medical Conditions: Renal (Q.2)

      Psychiatry & Co-Morbid Medical Conditions: Renal     This question series will focus on clinically relevant questions related to the role of psychotropic medications…

    Dr. Harvinder Singh April 20, 2018

    Psychiatry & Co-Morbid Medical Conditions- Renal (Q.1)

      Psychiatry & Co-Morbid Medical Conditions: Renal     This question series will focus on clinically relevant questions related to the role of psychotropic medications…

    Dr. Harvinder Singh April 6, 2018

    Psychiatry & Co-Morbid Medical Conditions: Hepatic (Q.3)

      Psychiatry & Co-Morbid Medical Conditions: Hepatic     This is our third question in this series: “Psychiatry and Co-Morbid Medical Conditions“. This post will…

    Dr. Harvinder Singh March 27, 2018

    Psychiatry & Co-Morbid Medical Conditions: Hepatic (Q.2)

      Psychiatry & Co-Morbid Medical Conditions: Hepatic       (Q.1) Which of the following psychotropic medication is not as influenced by first-pass metabolism? Sertraline…

    Dr. Harvinder Singh March 25, 2018

    Psychiatry & Co-Morbid Medical Conditions: Hepatic (Q.1)

      Psychiatry & Co-Morbid Medical Conditions: Hepatic     This is our first post in this series: “Psychiatry and Co-Morbid Medical Conditions“. This post will…

    Dr. Harvinder Singh March 24, 2018

    Antipsychotics use for psychosis/agitation management in dementia.

    Antipsychotics use for Psychosis or Agitation Management in Dementia -Post by Dr. Harvinder Singh. American Psychiatric Association (APA) have published detailed guidelines on this topic.…

    Dr. Harvinder Singh March 18, 2018
    2 Comments

    Marshall Protocol: antimicrobial treatment for chronic inflammatory diseases.

    Marshall Protocol: antimicrobial treatment for chronic inflammatory diseases.   Five key elements of this approach includes: taking a minimum of four doses of olmesartan (Benicar)…

    Dr. Harvinder Singh December 30, 2017

    Inflammatory Biomarkers and Risk of Schizophrenia

    Inflammatory Biomarkers and Risk of Schizophrenia   Question: Whether inflammatory biomarkers have an effect on the risk of developing schizophrenia.? Findings: This study published in JAMA Psychiatry…

    Dr. Harvinder Singh December 1, 2017

    FDA Approved NSS-2 BRIDGE for Opioid Withdrawal.

    FDA Approved NSS-2 BRIDGE for Opioid Withdrawal On November 15, 2017 U.S. Food and Drug Administration granted a new indication to an electric stimulation device for…

    Dr. Harvinder Singh November 16, 2017

    Hypothyroidism and Depression: Clinical Facts

    Hypothyroidism and Depression: Clinical Facts 1. Depressive patients have a higher frequency of hypothyroidism and patients with hypothyroidism have a higher occurrence of depressive syndrome. 2. Thyroid peroxidase…

    Dr. Harvinder Singh October 14, 2017

    Q.10: Which CYP450 is responsible for this conversion from trazodone to mCPP?

    Patients taking trazodone may get false positive results on the urine enzyme immunoassay test for MDMA. The reason for this false positive result is trazodone’s…

    Dr. Harvinder Singh September 27, 2017

    Q.11: Medications Affecting Lamotrigine Clearance ?

    Q.11: Which of the following medication is NOT known to increase the apparent clearance of lamotrigine? (a) Carbamazepine (b) Estrogen-containing oral contraceptives (c) Rifampin (d) Valproate (e)…

    Dr. Harvinder Singh September 27, 2017

    Antidepressants & Comorbid Medical Conditions

    Antidepressants & Comorbid Medical Conditions   Antidepressant to avoid in patients with seizure disorders: Buproprion Antidepressant to avoid in patients with uncontrolled hypertension: Venlafaxine Antidepressant…

    Dr. Harvinder Singh September 20, 2017

    Topiramate with Hydrochlorthiazide

          BEFORE SCROLLING DOWN ==> SUBMIT YOUR ANSWERS FIRST 🙂 . . . .     Answer: (b) Potassium followed by (d) Bicarbonate  …

    Dr. Harvinder Singh September 13, 2017

    VA/DOD Clinical Practice Guidelines for PTSD.

      BEFORE SCROLLING DOWN ==> SUBMIT YOUR ANSWERS FIRST 🙂 . . . .   According to VA/DOD recently published guidelines (June 2017):    For…

    Dr. Harvinder Singh August 29, 2017

    False Positive Urine Drug Screen

        BEFORE SCROLLING DOWN ==> SUBMIT YOUR ANSWERS FIRST 🙂 . . . .   Sertraline —> can cause false positive results for benzodiazepines…

    Dr. Harvinder Singh August 27, 2017

    Antidepressants in Bipolar Disorder: Clinical Facts

      Q.1: Monotherapy with Antidepressants is not recommended in patient with bipolar disorder. Which antidepressants are preferred in conjunction with mood stabilizer? SSRIs (other than…

    Dr. Harvinder Singh June 15, 2017

    Borderline Personality Disorder: Most Reliable Clinical Feature?

    Q: Presence of Which Single Clinical Feature Identifies Most Patients with Borderline Personality Disorder and Absence of Which Rules out this Disorder? Answer: Affective Instability. Zimmermen…

    Dr. Harvinder Singh June 4, 2017

    ADHD and Comorbid Bipolar Disorder

    ADHD and Comorbid Bipolar Disorder   Q: Which Symptoms are More Prominent in Bipolar Disorder-I, Compared with those with only ADHD? Elevated Mood Grandiosity Flight…

    Dr. Harvinder Singh April 10, 2017

    Role of Melatonin with Antipsychotic Induced Metabolic Effects

    Role of Melatonin With  Antipsychotic Induced Metabolic Effects   The following three randomized, double-blind, parallel-group, placebo-controlled clinical trials evaluated the metabolic effect of melatonin in patients…

    Dr. Harvinder Singh March 10, 2017

    Billing in Tobacco Use Disorder

    Billing in Tobacco Use Disorder   As of January 2011, Medicare covers face to face tobacco cessation counseling from a Medicare recognized practitioner (physician, physician assistant,…

    Dr. Harvinder Singh February 1, 2017

    When will you Initiate Statin Therapy?

    52 year old male with history of major depression disorder stable on fluoxetine 20 mg daily. Medical History: diabetes mellitus Labs: LDL-C: 130 mg/dL.  Will…

    Dr. Harvinder Singh January 25, 2017

    Dasotraline: New DNRI (Dopamine and Norepinephrine Reuptake Inhibitor)

    Dasotraline: New DNRI (Dopamine and Norepinephrine Reuptake Inhibitor) Dasotraline:   Dasotraline is an investigational medication discovered by Sunovion Pharmaceuticals Inc. and is currently under development…

    Dr. Harvinder Singh January 24, 2017

    Subclinical Hypothyroidism: Will you initiate thyroid replacement therapy?

      28 year old non pregnant female presents with symptoms of depression. On evaluation her thyroid-stimulating hormone (TSH) level is elevated with normal free thyroxine…

    Dr. Harvinder Singh January 22, 2017

    Personality Disorders- Differential Diagnosis

    (1) Cluster A Personality Disorders- Differential Diagnosis 1. Paranoid Personality Disorder Paranoid Personality Disorder Delusional disorder and Schizophrenia Reality testing intact Reality testing lost  …

    Dr. Harvinder Singh January 20, 2017

    Modifiable Predictors of Conversion to Dementia in Mild Cognitive Impairment

    Modifiable Predictors of Conversion to Dementia in Mild Cognitive Impairment (MCI) Diabetes: increases the risk of Alzheimer’s dementia in people with amnestic MCI and that…

    Dr. Harvinder Singh January 4, 2017

    10 Facts Regarding Personality Disorders

    10 Facts Regarding Personality Disorders (1) Personality disorders in cluster B are said to combine abnormalities in both thinking and affect, but not to be…

    Dr. Harvinder Singh December 7, 2016

    Bupropion: 10 Clinical Facts

    Bupropion: 10 Clinical Facts <h4><strong>Clinical Fact #1:</strong></h4> Bupropion is least likely to precipitate mania of all antidepressants in patient with bipolar disorder. Reference: N Engl…

    Dr. Harvinder Singh December 6, 2016

    Bipolar Disorder Type II vs Borderline Personality Disorder

    Bipolar Disorder Type II vs Borderline Personality Disorder Please do post your questions or comments below. 

    Dr. Harvinder Singh October 10, 2016

    Neuroleptic Malignant Syndrome Vs Serotonin Syndrome

    Copyright © Psychiatry Education Forum Please do post your questions or comments below.  Dr. Harvinder Singh, M.D. (Admin) Enroll in our online course to have access…

    Dr. Harvinder Singh October 3, 2016

    Join Academy Membership

    Most Recent Posts

    • Integrative and Complementary Psychiatry February 5, 2023
    • Hydroxychloroquine & Psychotropics Interaction February 3, 2023
    • Amazon RxPass: $5/month Generics January 30, 2023
    • MDD Augmentation: Low Dose Naltrexone January 29, 2023
    • MDD Augmentation: S-Adenosyl Methionine (SAMe) January 28, 2023
    • MDD Augmentation: Pramipexole January 26, 2023
    • MDD Augmentation: Buspirone January 22, 2023
    • MDD Augmentation: Stimulants January 22, 2023
    • MDD Augmentation: Lamotrigine January 21, 2023
    • MDD Augmentation: L-MethylFolate January 19, 2023
    • MDD Augmentation: Thyroid Hormone January 15, 2023
    • MDD Augmentation: Lithium January 15, 2023
    • MDD Augmentation: Atypical Antipsychotics January 13, 2023

    Please note that this website is for educational purposes only and do refer to sources cited at the end of each topics for more information. Psychiatry Education Forum and authors do not assume any liability or responsibility for damage, injury, or death to you, other persons or property from any use of any ideas, information, or instruction in this website.

    Psychiatry Education Forum
    © 2023 - Psychiatry Education Forum   DISCLAIMER: Please note that this website is for educational purposes only and do refer to sources cited at the end of each topic for more information. Psychiatry Education Forum and authors do not assume any liability or responsibility for damage, injury, or death to you, other persons, or property from any use of any ideas, information, or instruction in this website.

    Report

    There was a problem reporting this post.

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Contains spam, fake content or potential malware

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Invite this member to groups
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

    Report

    You have already reported this .